title: Catechol metabolites of the mycotoxin zearalenone are poor substrates but potent inhibitors of catechol-O-methyltransferase.
abstract: The mycotoxin zearalenone (ZEN) elicits estrogenic effects and is biotransformed to two catechol metabolites, in analogy to the endogenous steroidal estrogen 17ß-estradiol (E2). Previous studies have shown that the catechol metabolites of ZEN have about the same potency to induce oxidative DNA damage as the catechol metabolites of E2, but are less efficiently converted to their methyl ethers by human hepatic catechol-O-methyltransferase (COMT). Here, we report that the two catechol metabolites of ZEN, i.e. 13-hydroxy-ZEN and 15-hydroxy-ZEN, are not only poor substrates of human COMT but are also able to strongly inhibit the O-methylation of 2-hydroxy-E2, the major catechol metabolite of E2. 15-Hydroxy-ZEN acts as a non-competitive inhibitor and is about ten times more potent than 13-hydroxy-ZEN, which is an uncompetitive inhibitor of COMT. The catechol metabolites of ZEN were also shown to inhibit the O-methylation of 2-hydroxy-E2 by hepatic COMT from mouse, rat, steer and piglet, although to a lesser extent than observed with human COMT. The powerful inhibitory effect of catechol metabolites of ZEN on COMT may have implications for the tumorigenic activity of E2, because catechol metabolites of E2 elicit genotoxic effects, and their impaired O-methylation may increase the tumorigenicity of steroidal estrogens.
authors.affiliation: Institute of Applied Biosciences, Unit of Food Toxicology, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.
authors.forename: Erika
authors.initials: E
authors.lastname: Pfeiffer
authors.forename: Daniel
authors.initials: D
authors.lastname: Wefers
authors.forename: Andreas A
authors.initials: AA
authors.lastname: Hildebrand
authors.forename: Stefanie C
authors.initials: SC
authors.lastname: Fleck
authors.forename: Manfred
authors.initials: M
authors.lastname: Metzler
mesh_terms: D000818:Animals; D001711:Biotransformation; D002394:Catechol O-Methyltransferase / Q000378:metabolism*; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000378:metabolism*; D006801:Humans; D009153:Mutagens / Q000378:metabolism; D009183:Mycotoxins / Q000378:metabolism*; D015025:Zearalenone / Q000378:metabolism*
chemical_list: D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols; D004791:Enzyme Inhibitors; D009153:Mutagens; D009183:Mycotoxins; D015025:Zearalenone; D002394:Catechol O-Methyltransferase
references.citation: Chem Res Toxicol. 2007 Oct;20(10):1409-25
references.pmid: 17880176
references.citation: Xenobiotica. 2008 Feb;38(2):130-46
references.pmid: 18197555
references.citation: Toxicol Lett. 2012 Apr 5;210(1):9-14
references.pmid: 22285433
references.citation: Mycotoxin Res. 2012 Nov;28(4):267-73
references.pmid: 23606198
references.citation: Toxicol Appl Pharmacol. 1994 Mar;125(1):149-58
references.pmid: 8128490
references.citation: Mutat Res. 1990 May;238(3):269-76
references.pmid: 2160607
references.citation: Mol Nutr Food Res. 2009 Sep;53(9):1123-33
references.pmid: 19655315
references.citation: J Steroid Biochem Mol Biol. 2011 Jul;125(3-5):169-80
references.pmid: 21397019
references.citation: J Biol Chem. 1994 Jan 7;269(1):292-9
references.pmid: 8276810
references.citation: Chem Res Toxicol. 2008 Jan;21(1):93-101
references.pmid: 18052105
references.citation: Cancer Res. 1998 Jun 1;58(11):2269-77
references.pmid: 9622057
references.citation: Drug Metab Dispos. 2004 May;32(5):497-504
references.pmid: 15100171
references.citation: Mycotoxin Res. 2011 Feb;27(1):1-3
references.pmid: 23605616
references.citation: Cancer Res. 2000 Jan 15;60(2):235-7
references.pmid: 10667565
references.citation: Ann N Y Acad Sci. 2006 Nov;1089:286-301
references.pmid: 17261777
references.citation: Curr Drug Metab. 2002 Jun;3(3):321-49
references.pmid: 12083324
references.citation: J Biol Chem. 1996 Jan 19;271(3):1357-63
references.pmid: 8576124
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Carcinogenesis. 1998 Jan;19(1):1-27
references.pmid: 9472688
references.citation: Hum Reprod Update. 2001 May-Jun;7(3):273-81
references.pmid: 11392373
references.citation: Mycotoxin Res. 2012 Feb;28(1):1-8
references.pmid: 23605977
references.citation: Int J Androl. 2010 Apr;33(2):369-76
references.pmid: 20002219
references.citation: Cancer Metastasis Rev. 2000;19(1-2):173-9
references.pmid: 11191057
references.citation: Natl Toxicol Program Tech Rep Ser. 1982 Oct;235:1-155
references.pmid: 12778201
references.citation: J Steroid Biochem. 1986 Jan;24(1):353-6
references.pmid: 3009986
references.citation: N Engl J Med. 2006 Jan 19;354(3):270-82
references.pmid: 16421368
references.citation: Food Chem Toxicol. 2007 Jan;45(1):1-18
references.pmid: 17045381